Transaction #11413 · Form 4 · 0001193125-25-291462
ASHLAND INC. · Stock award · Restricted Stock Units
ASHLAND INC. · Transacted November 19, 2025 · Filed November 21, 2025
What does this filing report?
An SEC Form 4 filing for ASHLAND INC. records a stock award involving Restricted Stock Units on November 19, 2025. The reported quantity was 6,136. The filing date is November 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ASHLAND INC.
- Company CIK
- 0001674862
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 6,136
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 6,136
- Ownership description
- Not reported
- SEC acceptance time
- Nov 21, 2025, 4:30 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Assis Alessandra Faccin ↗
SVP and GM, Life Sciences
CIK 0001931500
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 6,136
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of ASH Common Stock.
- F2
- Grant of Restricted Stock Units on November 19, 2025, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the issuer.
- F3
- Stock Appreciation Rights (SARs) granted under the Ashland Inc. 2021 Omnibus Incentive Compensation Plan.
- F4
- SARs become exercisable ratably over three years beginning on the first anniversary from the date of grant.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.